FDA Approves Roche Pill Combo for Advanced Breast Cancer

getfile.aspx

he U.S. Food and Drug Administration approved Roche's oral treatment for certain patients with advanced breast cancer, the regulator said Monday.The drug, giredestrant, was approved in combination with everolimus for adults with estrogen receptor-positive, HER2-negative,...

Continue reading...

[ H/T Newsmax ]
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read

Comments

There are no comments to display
Back
Top